New Partnership to Develop Gene Therapy for Cystic Fibrosis
Boehringer Ingelheim steps into the field of gene therapy with experienced partners to jointly develop first gene therapy for cystic fibrosis
Search
Spiriva®
Maintenance treatment of patients with COPD (including chronic bronchitis and emphysema), maintenance treatment of associated dyspnoea and for prevention of exacerbations.
Animal Health Partnering Interests Infectious Diseases May 2024 CORP
Animal Health Partnering Interests Cardiometabolic Diseases May 2024 CORP
Animal Health Partnering Interests CNS Diseases May 2024 CORP
ACCESSIBLE_Stargardt_Disease
Stargardt_Disease
Cardiovascular renal and metabolic diseases infographic
Our_Inflammatory_Disease_Research.pdf
CardioMetabolic_diseases.pdf
Cardiometabolic_Diseases.pdf
Central_Nervous_System_Diseases.pdf
stargardt_disease_infographic.pdf
Partnering in Infectious Diseases MAY 2024 CORP_0.pdf
Chronic Obstructive Pulmonary Disease
Partnering in Cardiometabolic Diseases MAY 2023 Corp
Partnering in CNS Diseases MAY 2024 CORP_0.pdf
Partnering in Cardiometabolic Diseases MAY 2024 CORP_0.pdf
Cardiovascular Disease
The Global Cardiovascular Disease Burden.pdf
The Global Cardiovascular Disease Burden.pdf
Kidney_Disease_in_Type_2_Diabetes.pdf
Heart disease modulator
European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares
European Commission grants marketing authorization for spesolimab, the first specific treatment option for generalized pustular psoriasis flares in adults
Diabetic Retinopathy
Diabetic retinopathy affects 1 in 3 people with diabetes and is the leading cause of vision loss in adults of working age.